
Información del producto
- N-(4-(2-(2-Propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide
FGH10019 is a novel fatty acid that has been shown to inhibit tumor growth in vitro and in vivo. It was found to inhibit aerobic glycolysis, which is an important biochemical pathway for cancer cell proliferation. FGH10019 also inhibits the biosynthesis of fatty acids, which may lead to metabolic disorders such as insulin resistance and hyperproliferative disorders such as pancreatitis.
Propiedades químicas
Consulta técnica sobre: 3D-WRB04561 FGH10019
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.